Regeneron Pharmaceuticals, Inc. (LON:0R2M)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	55,450	58,841	61,217	73,329	63,953	48,764
Market Cap Growth	-10.34%	-3.88%	-16.52%	14.66%	31.15%	30.57%
Enterprise Value	43,671	46,935	48,770	63,131	55,414	42,324
Last Close Price	542.51	575.10	560.58	684.94	588.10	467.81
PE Ratio	16.57	17.58	17.37	23.63	17.76	8.18
PS Ratio	5.20	5.52	5.40	7.12	6.33	4.11
PB Ratio	2.39	2.53	2.61	3.60	3.40	3.52
P/TBV Ratio	2.49	2.64	2.72	3.75	3.54	3.52
P/FCF Ratio	-	-	20.91	24.10	17.42	10.11
P/OCF Ratio	-	-	17.34	20.33	15.37	9.32
EV/Sales Ratio	4.18	4.40	4.30	6.13	5.49	3.57
EV/EBITDA Ratio	14.07	14.83	13.19	17.28	12.51	6.18
EV/EBIT Ratio	16.07	16.95	14.73	19.00	13.37	6.37
EV/FCF Ratio	-	-	16.66	20.75	15.09	8.78
Debt / Equity Ratio	0.09	0.09	0.10	0.11	0.12	0.14
Debt / EBITDA Ratio	0.64	0.64	0.63	0.60	0.52	0.29
Debt / FCF Ratio	-	-	0.80	0.72	0.63	0.41
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.76
Inventory Turnover	2.53	2.53	2.51	2.51	2.37	2.74
Quick Ratio	4.22	4.22	3.86	4.82	4.16	2.98
Current Ratio	4.77	4.77	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	5.95%	5.95%	7.31%	8.49%	11.42%	26.39%
Return on Invested Capital (ROIC)	15.93%	16.73%	18.58%	22.38%	26.65%	60.13%
Return on Capital Employed (ROCE)	10.70%	10.70%	12.30%	14.30%	19.20%	41.80%
Earnings Yield	6.04%	5.69%	5.76%	4.23%	5.63%	12.23%
FCF Yield	-	-	4.78%	4.15%	5.74%	9.89%
Dividend Yield	0.36%	0.46%	-	-	-	-
Buyback Yield / Dilution	5.65%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	6.01%	6.10%	-1.23%	-0.18%	-1.16%	2.52%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.